1-methyl-3-isobutylxanthine has been researched along with mopidamol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adolfs, MJ; Bonta, IL; Parnham, MJ | 1 |
Atwood, HL; Dixon, D | 1 |
Macfarlane, DE | 1 |
3 other study(ies) available for 1-methyl-3-isobutylxanthine and mopidamol
Article | Year |
---|---|
Mimickry of anti-granuloma effect of prostaglandin E by dibutyryl cyclic-AMP and some phosphodiesterase inhibitors.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Anti-Inflammatory Agents; Bucladesine; Disease Models, Animal; Inflammation; Mopidamol; Phosphodiesterase Inhibitors; Prostaglandins E; Rats; Theophylline | 1979 |
Adenylate cyclase system is essential for long-term facilitation at the crayfish neuromuscular junction.
Topics: 1-Methyl-3-isobutylxanthine; Adenine; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Astacoidea; Bacterial Toxins; Colforsin; Cyclic AMP; GTP-Binding Proteins; Mopidamol; Neuromuscular Junction; Phospholipases; Protein Kinase Inhibitors; Time Factors | 1989 |
Inhibitors of cyclic nucleotide phosphodiesterases inhibit protein carboxyl methylation in intact blood platelets.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Dipyridamole; Humans; Hydrogen-Ion Concentration; Hydrolysis; Methionine; Mopidamol; Papaverine; Protein Methyltransferases; Protein O-Methyltransferase; S-Adenosylmethionine | 1984 |